Johnson & Johnson Reports Earnings, Notably Lowers EOY Outlook
Johnson & Johnson reported a miss on its Q1 earnings just shy of analyst expectations. The pharmaceutical giant also noted that it has an excess of COVID-19 vaccines and that it will be lowering its end-of-year earnings outlook for 2022.
Kim Crawford Goodman, CEO of Smarsh, breaks down how financial firms are scaling AI while managing compliance, risk, and regulation in a changing landscape.
Elizabeth Renter, Senior Economist at NerdWallet, breaks down how inflation and oil price shocks are driving higher costs and squeezing consumers today.
David Branch of Wells Fargo explains why cocoa prices are falling but some candy costs remain high and when consumers may finally see relief at checkout.
